The next generation of autoinjectors...

Oval was born out of the belief that a novel primary drug containment technology could revolutionise the autoinjector market, and provide radical improvements in the safety, acceptability and reliability of needle-based self-administration.

Oval's core technology has the flexibility to deliver a wide range of autoinjectors to suit all patient groups, from children to elderly patients with dexterity problems.